Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Numerous studies have shown the diagnostic interest of cerebrospinal fluid kappa free light chains and kappa index in multiple sclerosis. However, large cohort studies are lacking and little is known about the correlation between kappa and lambda indexes and multiple sclerosis evidence disease activity. Therefore, this study plan to validate the kappa and lambda free light chains and indexes as diagnostic biomarker in multiple sclerosis and to correlate the concentration of kappa and lambda free light chains with clinical and radiological activity in a large cohort of patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Mutliple sclerosis |
| ||
| CIS/RIS |
| ||
| Other CNS inflammatory diseases |
| ||
| Non inflammatory CNS diseases |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Biological collection | Other | Collection of cerebrospinal fluid kappa and lambda free light chains and indexes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of cerebrospinal fluid (CSF) and serum kappa and lambda free light chains (KFLC and LFLC) |
| 1 day |
| Measurement of cerebrospinal fluid (CSF) and serum albumin |
| 1 day |
| Evaluation of the diagnostic performances of KFLC and LFLC intrathecal synthesis biomarkers (K/L FLC index and K/L FLC intrathecal fraction (IF)) for multiple sclerosis |
| 1 day |
| Comparison of diagnostic performances of K/L FLC intrathecal synthesis biomarkers to oligoclonal bands (OCB) for multiple sclerosis |
|
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of clinical data that can alter KFLC and LFLC values | Identification of data that can be independtly associated with high or low CSF KFLC or LFLC values as potential bias in K/L FLC intrathecal synthesis biomarkers interpretation:
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients presenting with symptoms evocative of CNS disease
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Hospitalier Universitaire de Clermont-Ferrand | Clermont-Ferrand | France | ||||
| Centre Hospitalier Universitaire de Dijon |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 day |
| 1 day |
| Dijon |
| France |
| Centre Hospitalier Universitaire de Grenoble | Grenoble | France |
| Centre Hospitalier Universitaire de Lille | Lille | France |
| Assistance Publique des Hôpitaux de Marseille | Marseille | France |
| Centre Hospitalier Universitaire de Montpellier | Montpellier | France |
| Centre Hospitalier Universitaire de Nantes | Nantes | France |
| Centre Hospitalier Universitaire de Nice | Nice | France |
| Centre Hospitalier Universitaire de Nîmes | Nîmes | France |
| Assistance Publique des Hôpitaux de Paris | Paris | France |
| Centre Hospitalier Universitaire de Saint-Etienne | Saint-Etienne | France |
| Centre Hospitalier Universitaire de Strasbourg | Strasbourg | France |
| Centre Hospitalier Universitaire de Toulouse | Toulouse | France |
| Centre Hospitalier Régional et Universaitaire de Tours | Tours | France |
| ID | Term |
|---|---|
| D002493 | Central Nervous System Diseases |
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D009422 | Nervous System Diseases |
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D003711 | Demyelinating Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided